Asset 2 Conferences
Cancer Biology

Recent insights into Immuno-Oncology

16-17 June 2022, Leuven, Belgium
Immuno Oncology - campaign visual

Recent insights into Immuno-Oncology

Recent insights into Immuno-Oncology
Keep me postedAdd to calendar

Cancer immunotherapy has recently become a crucial pillar of anticancer therapy. This is mainly because of the unmatched long-term responses elicited by immune checkpoint blockers and T cell-based therapies in patients with advanced cancer. In spite of this, the efficacy of these therapeutics is still limited to certain patients and cancer types, largely because of a variety of resistance mechanisms in tumors that are currently being identified. Understanding the dialogue between cancer cells and the immune system and the molecular mechanisms by which immune checkpoints regulate anti-tumor immunity are essential cornerstones for the improvement of cancer immunotherapy.

This upcoming conference brings together leaders with young investigators engaged in the fields of Immuno-Oncology, immunometabolism and cellular therapies, with the main scope of sharing new insights into the immune response to tumors and tackle unresolved questions.

We anticipate that the conference will provide a perfect forum to stimulate discussion and interaction among participants, clinicians and experts of the burgeoning and rapidly evolving field of Immuno-Oncology.

The program brings together world recognized experts who will present their recent work in sessions focused on:

  • Cross talk myeloid cells
  • Immunometabolism
  • Clinical or translational
  • T Cell/ Immunotherapy
  • Precision Immuno-Oncology
  • Immune escape


Next to an inspiring scientific program, conference participants will have ample networking opportunities during the breaks, poster sessions and the conference dinner in a perfectly safe and stimulating environment.

Wednesday 15 June 19:00 - Public lecture - Facing cancer: a new generation of immunotherapy heads for the clinic
VIB organizes a free public lecture by tumor immunology expert Benoît Van den Eynde on the evening before the conference. The evening will be opened with a lecture by the co-directors of the VIB-KU Leuven Center for Cancer Biology, Chris Marine and Diether Lambrechts. The evening will end with a reception. The lecture will be in English and everyone is welcome. Admission is free, but registration is required. You can register by adding the public lecture ticket below.

Find out more about the public lecture here.

Information for poster presenters
The format for your poster should be: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation.
You can find the poster list here.

Host City: Leuven
Want to know more about the host city of this conference? Find out where the best restaurants, bars or last minute print shops are? Check the city page here.

Share

Confirmed speakers

Seth Coffelt
Coffelt, Seth - VIB Conferences
Seth Coffelt

Seth Coffelt

Institute of Cancer Sciences at the University of Glasgow and Cancer Research UK Beatson Institute, UK
Susan Kaech
Kaech Susan - VIB Conferences
Susan Kaech

Susan Kaech

NOMIS Center for Immunobiology & Microbial Pathogenesis, Salk Institute for Biological Studies, US

Program

Day 1 - Thursday, 16 June, 2022

08:30
09:00
Registration and welcome coffee
09:00
09:15
Welcome word
Session 1: Cross talk myeloid cells
09:15
09:45
A tumor agnostic dendritic cell vaccine

Michele De Palma

Swiss Federal Institute of Technology in Lausanne (EPFL) and Agora Cancer Research Center, Lausanne, CH
09:45
10:15
Necrophagia, DaNGeRous indigestion and immunity to cancer
10:15
10:45
Coffee break
10:45
11:15
Generation and functions of pro-metastatic neutrophils
11:15
11:20
Poster pitch: Lymphatic endothelial cell autophagy control of S1P shapes lymphocyte trafficking in the lymph node and T cell mediated anti-tumor immune responses

Diede Houbaert

Cell Death Research and Therapy (CDRT) Laboratory, Department of Cellular and Molecular Medicine, KU Leuven-VIB, Belgium, BE
Selected from abstracts
11:20
11:25
Poster pitch: Radiotherapy modulates macrophage-cancer cell crosstalk: an opportunity towards the development of novel Immunomodulatory therapies
Selected from abstracts
11:25
11:30
Poster pitch: Mucosal vaccination with a viral vector vaccine induces robust lung-resident T cell responses and protects against 4T1 metastasis
11:30
11:35
Poster pitch: IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer
Selected from abstracts
11:35
11:40
Poster pitch: Deep T cell receptor sequencing reveals common and reproducible T cell receptor signatures of response to checkpoint immunotherapy

Robert Watson

Oxford University Hospitals NHS Foundation Trust, UK; University of Oxford, UK
Selected from abstracts
11:45
11:50
Explore the next step in ultrahigh-content imaging: the MACSima imaging platform

Veerle Lemmens

Imaging Specialist BeNeLux Miltenyi Biotec, BE
Sponsored talk
11:50
12:45
Lunch
12:45
13:45
Poster session 1
Session 2: Immunometabolism
13:45
14:15
Immunoediting instructs tumor metabolic reprogramming to support immune evasion

Ping-Chih Ho

University of Lausanne/Ludwig Institute for Cancer Research, CH
14:15
14:45
Co-opting immune cells to support cancer progression through metabolic reprogramming

Susan Kaech

NOMIS Center for Immunobiology & Microbial Pathogenesis, Salk Institute for Biological Studies, US
14:45
15:15
Functional genomics of T cell metabolism and immuno-oncology
15:15
15:30
Harnessing CD8+ T cell metabolism to improve their anti-tumor immune response in pancreatic cancer
Selected from abstracts
15:30
16:00
Coffee break
Session 3: Clinical or translational
16:00
16:30
Personalized whole tumor lysate vaccines in the new era of neo-antigens

Lana Kandalaft

Ludwig Institute for Cancer Research, Lausanne Branch (LICR) / CHUV / UNIL, CH
16:30
17:00
Overcoming innate-immune resistance in cancer

Nina Bhardwaj

The Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai, US
17:00
17:15
PD-L1 checkpoint blockade promotes regulatory T-cell activity which underlies therapy resistance
Selected from abstracts
17:15
17:45
Microbiota in cancer progression and metastases
17:45
18:45
Meet the speaker / editor session and reception
18:45
19:45
Guided walk
20:00
22:30
Conference dinner

Day 2 - Friday, 17 June, 2022

08:30
09:00
Welcome coffee
Session 4: T Cell/ Immunotherapy
09:00
09:30
T-cell dynamics in melanoma patients receiving TIL therapy and generation of enriched cell products

Alexandre Harari

Department of oncology UNIL CHUV Ludwig Institute for Cancer Research Lausanne, CH
09:30
10:00
Tissue-resident gamma delta T cell function during tumor initiation, metastasis and immunotherapy treatment

Seth Coffelt

Institute of Cancer Sciences at the University of Glasgow and Cancer Research UK Beatson Institute, UK
10:00
10:30
Regulatory T cells as determinants of adaptive and innate immune function in brain tumours
10:30
10:45
The role of tumor-specific CD4 T cells in CD8 T cell-mediated anti-tumor immunity
10:45
11:15
Coffee break
Session 5: Precision Immuno-Oncology
11:15
11:45
Dissecting and modulating reactive anti-tumor immunity in human cancers
11:45
12:15
Towards deciphering the highly heterogeneous peptidomic landscape in melanoma

Yardena Samuels

Department of Molecular Cell Biology, Weizmann Institute of Science, IL
12:15
12:45
Informing precision immuno-oncology

Zlatko Trajanoski

Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, AT
12:45
13:00
Better biomarker for response to immune checkpoint inhibition therapy: Analysis of neoepitope immunogenicity by neoIM
13:00
13:05
Multi-Omic Tools for Therapeutic Discovery, Translational Research and Accelerating Clinical Outcomes

Harry Veerman

Benelux Senior Sales Manager, Fluidigm, NL
Sponsored talk
13:05
13:45
Lunch
13:45
14:45
Poster session 2
Session 6: Immune escape
14:45
15:15
CD8 T cells at the intersection of cancer and autoimmunity
15:15
15:45
Downregulation of the T cell activating receptor CD226 drives resistance to cancer immunotherapy

Tobias Bald

Institute of Experimental Oncology, University Hospital Bonn, DE
15:45
16:15
Coffee break
16:15
16:45
Regulation of myeloid-derived suppressor cells in cancer
16:45
17:15
Nanobody-mediated modulation of immunosuppressive cells in the tumor microenvironment
17:15
17:30
Closing remarks and poster prizes ceremony

Organizing committee

Abstracts

The full list of abstracts will be available on 09-06-2022 until 15-07-2022
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 09-06-2022 until 15-07-2022
This list will only be available for registered attendees of the event.